Alnylam Pharmaceuticals, Inc Shs Unsponsored Brazilian Depository Receipt Repr 0.05 Sh (A1LN34) Price & Analysis

― Followers

A1LN34 Stock Chart & Stats

R$55.50

-R$0.40(-0.72%)

Aug 04, 2026

―

Day’s Range― - ―

52-Week RangeR$10.00 - R$135.00

Previous CloseN/A

VolumeN/A

Average Volume (3M)327.00

Market Cap

R$139.59B

Enterprise ValueR$210.38K

Total Cash (Recent Filing)N/A

Total Debt (Recent Filing)N/A

Price to Earnings (P/E)33055.5

Beta-0.13

Next Earnings

Oct 29, 2026

EPS EstimateN/A

Next Dividend Ex-DateN/A

Dividend YieldN/A

Share Statistics

EPS (TTM)0.00

Shares Outstanding2,676,182,400

10 Day Avg. Volume53

30 Day Avg. Volume327

Financial Highlights & Ratios

PEG RatioN/A

Price to Book (P/B)N/A

Price to Sales (P/S)N/A

P/FCF RatioN/A

Enterprise Value/Market CapN/A

Enterprise Value/RevenueN/A

Enterprise Value/Gross ProfitN/A

Enterprise Value/EbitdaN/A

Forecast

1Y Price TargetN/A

Price Target UpsideN/A

Rating ConsensusN/A

Number of Analyst Covering0

EPS Forecast (FY)N/A

Revenue Forecast (FY)N/A

Alnylam Pharmaceuticals, Inc Shs Unsponsored Brazilian Depository Receipt Repr 0.05 Sh News

Alnylam price target lowered to $325 from $400 at Evercore ISI

Evercore ISI lowered the firm’s price target on Alnylam (ALNY) to $325 from $400 and keeps an Outperform...

8h ago

ALNY

Alnylam price target lowered to $455 from $485 at H.C. Wainwright

H.C. Wainwright lowered the firm’s price target on Alnylam (ALNY) to $455 from $485 and keeps a Buy...

1d ago

ALNY

Alnylam price target lowered to $315 from $410 at Truist

Truist lowered the firm’s price target on Alnylam (ALNY) to $315 from $410 and keeps a Buy rating...

1d ago

ALNY

Starbucks upgraded, eBay downgraded: Wall Street’s top analyst calls

The most talked about and market moving research calls around Wall Street are now in one place. Here...

2d ago

Alnylam upgraded to Strong Buy from Outperform at Raymond James

Raymond James upgraded Alnylam (ALNY) to Strong Buy from Outperform with an unchanged price target of $420. The...

2d ago

ALNY

Alnylam price target lowered to $340 from $380 at Citi

Citi lowered the firm’s price target on Alnylam (ALNY) to $340 from $380 and keeps a Buy rating...

3d ago

ALNY

Alnylam price target lowered to $450 from $527 at Barclays

Barclays analyst Eliana Merle lowered the firm’s price target on Alnylam (ALNY) to $450 from $527 and keeps...

3d ago

ALNY

Alnylam price target lowered to $346 from $410 at BofA

BofA lowered the firm’s price target on Alnylam (ALNY) to $346 from $410 and keeps a Buy rating...

5d ago

ALNY

Alnylam price target lowered to $420 from $468 at Raymond James

Raymond James analyst Martin Auster lowered the firm’s price target on Alnylam (ALNY) to $420 from $468 and...

5d ago

ALNY

Alnylam price target lowered to $350 from $500 at Oppenheimer

Oppenheimer lowered the firm’s price target on Alnylam (ALNY) to $350 from $500 and keeps an Outperform rating...

5d ago

ALNY

A1LN34 FAQ

What was Alnylam Pharmaceuticals, Inc Shs Unsponsored Brazilian Depository Receipt Repr 0.05 Sh’s price range in the past 12 months?

Alnylam Pharmaceuticals, Inc Shs Unsponsored Brazilian Depository Receipt Repr 0.05 Sh lowest stock price was R$10.00 and its highest was R$135.00 in the past 12 months.

What is Alnylam Pharmaceuticals, Inc Shs Unsponsored Brazilian Depository Receipt Repr 0.05 Sh’s market cap?

Alnylam Pharmaceuticals, Inc Shs Unsponsored Brazilian Depository Receipt Repr 0.05 Sh’s market cap is R$139.59B.

When is Alnylam Pharmaceuticals, Inc Shs Unsponsored Brazilian Depository Receipt Repr 0.05 Sh’s upcoming earnings report date?

Alnylam Pharmaceuticals, Inc Shs Unsponsored Brazilian Depository Receipt Repr 0.05 Sh’s upcoming earnings report date is Oct 29, 2026 which is in 85 days.

How were Alnylam Pharmaceuticals, Inc Shs Unsponsored Brazilian Depository Receipt Repr 0.05 Sh’s earnings last quarter?

Alnylam Pharmaceuticals, Inc Shs Unsponsored Brazilian Depository Receipt Repr 0.05 Sh released its earnings results on Jul 30, 2026. The company reported R$0 earnings per share for the quarter, missing the consensus estimate of N/A by N/A.

Is Alnylam Pharmaceuticals, Inc Shs Unsponsored Brazilian Depository Receipt Repr 0.05 Sh overvalued?

According to Wall Street analysts Alnylam Pharmaceuticals, Inc Shs Unsponsored Brazilian Depository Receipt Repr 0.05 Sh’s price is currently Undervalued. Get more investment ideas with TipRanks Premium

Does Alnylam Pharmaceuticals, Inc Shs Unsponsored Brazilian Depository Receipt Repr 0.05 Sh pay dividends?

Alnylam Pharmaceuticals, Inc Shs Unsponsored Brazilian Depository Receipt Repr 0.05 Sh does not currently pay dividends.

What is Alnylam Pharmaceuticals, Inc Shs Unsponsored Brazilian Depository Receipt Repr 0.05 Sh’s EPS estimate?

Alnylam Pharmaceuticals, Inc Shs Unsponsored Brazilian Depository Receipt Repr 0.05 Sh’s EPS estimate for its next earnings report is not yet available.

How many shares outstanding does Alnylam Pharmaceuticals, Inc Shs Unsponsored Brazilian Depository Receipt Repr 0.05 Sh have?

Alnylam Pharmaceuticals, Inc Shs Unsponsored Brazilian Depository Receipt Repr 0.05 Sh has 2,676,182,400 shares outstanding.

What happened to Alnylam Pharmaceuticals, Inc Shs Unsponsored Brazilian Depository Receipt Repr 0.05 Sh’s price movement after its last earnings report?

Alnylam Pharmaceuticals, Inc Shs Unsponsored Brazilian Depository Receipt Repr 0.05 Sh reported an EPS of R$0 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went down -32.973%.

Which hedge fund is a major shareholder of Alnylam Pharmaceuticals, Inc Shs Unsponsored Brazilian Depository Receipt Repr 0.05 Sh?

Currently, no hedge funds are holding shares in BR:A1LN34

What is the TipRanks Smart Score and how is it calculated?

Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology